I recall the days when the idea
of developing practice guidelines was first discussed, an idea that was not
free of controversy. Many feared that it would encourage "cookbook medicine" (a
sentiment also expressed by some about the criteria-based system of DSM-III). At
the time (the late 1980s and early 90s), the field was transitioning from a
long tradition when clinical expertise and theory guided our treatment
recommendations to a more evidence-based approach. A two-day conference was
held in Washington, D.C., in 1992, titled "Challenges in Developing Psychiatric
Practice Guidelines," cochaired by Jack McIntyre and
me. I chaired the second day of the conference, which was dedicated to what we
thought of at the time as "Track II" conditions—those that were prevalent in
clinical treatment populations, but about which there was little published
research. We called the second day of the conference "New Methods in Guideline
Development: What to Do When the Database Is Incomplete," and the "poster"
example I presented was borderline personality disorder (BPD). We were
wrestling with how to establish a standardized process to develop treatment
recommendations based largely on a consensus of clinical experts, in cases
where research was still in its early stages.